Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Azelnidipine preparation with combination of two disintegrating agents and preparation method of azelnidipine preparation

A technology of azedipine and disintegrant, which is applied in the field of azedipine preparations and its preparation, can solve the problems of undisclosed dosage forms for rapid release of drugs, and does not involve dissolution curve fitting, so as to achieve the effect of saving manpower and material resources

Active Publication Date: 2014-01-22
NANJING CHIA TAI TIANQING PHARMA
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But these patents all do not disclose the dosage form that can reach medicine rapid release, more do not relate to and commercially available Fitting of the dissolution curve

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Azelnidipine preparation with combination of two disintegrating agents and preparation method of azelnidipine preparation
  • Azelnidipine preparation with combination of two disintegrating agents and preparation method of azelnidipine preparation
  • Azelnidipine preparation with combination of two disintegrating agents and preparation method of azelnidipine preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment A

[0025]

[0026] Preparation process: pass the azedipine, lactose, microcrystalline cellulose, carmellose calcium and low-substituted hydroxypropyl cellulose in the prescription through a 60-mesh sieve twice, mix well, add magnesium stearate, mix well Compressed into tablets.

Embodiment B

[0028]

[0029]

[0030] Preparation process: pass the azelnidipine, mannitol, carmellose calcium, low-substituted hydroxypropyl cellulose and micropowder silica gel in the prescription twice through a 60-mesh sieve, mix well, add magnesium stearate, mix well Pressed into tablets.

Embodiment C

[0032]

[0033] Preparation process: pass the azedipine, microcrystalline cellulose, mannitol, carmellose calcium and low-substituted hydroxypropyl cellulose in the prescription through a 60-mesh sieve twice, mix well, add magnesium stearate, mix well Compressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an azelnidipine preparation with combination of two disintegrating agents. The azelnidipine preparation is prepared from azelnidipine, two combined disintegrating agents in different proportions and other pharmaceutic adjuvants, wherein the combined disintegrating agents are prepared from calcium carboxymethyl celluloses and low-substituted hydroxypropyl celluloses; the adding amount of the calcium carboxymethyl celluloses accounts for 13% to 120% of that of the low-substituted hydroxypropyl celluloses; the other pharmaceutic adjuvants contain one or multiple types of filling agents, adhesives or lubricants. The azelnidipine preparation is simple in preparation method and controllable in quality, and has the high fitting degree with the in-vitro stripping curve of a product prepared by a specified pharmaceutical factory while having the bioequivalence at the same time. Thus, the efficacy and safety of the azelnidipine preparation in clinical applications are ensured.

Description

technical field [0001] The invention relates to a pharmaceutical dosage form of a dihydropyridine calcium ion antagonist, in particular to an azendipine preparation and its preparation. Background technique [0002] Azelnidipine, whose English name is Azelnidipine, has the following structural formula. [0003] [0004] Azedipine is a dihydropyridine calcium channel blocker, which was jointly developed by Sankyo Company and Ube Company of Japan and was first listed in Japan in 2003. The trade name is It is widely used because of its reliable antihypertensive effect. It is clinically used for the treatment of mild to moderate hypertension. It is characterized by a long duration of action and mild action. [0005] In the research and application of oral preparations of azeldipine, it is found that its bioavailability is relatively low, and one of the important reasons is that its dissolution is slow and incomplete. commercially available Surfactant Tween-80 was added t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/38A61K31/4427A61K9/20A61P9/12
Inventor 龙苗苗顾亚军章晓骅徐丹杨治旻田舟山
Owner NANJING CHIA TAI TIANQING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com